Join our team in Bologna, Italy for the Controlled Release Society’s 2024 annual meeting. This year’s conference theme is “Integrating Delivery Science Across Disciplines”, building on the notion that daily activities rely on the continuous integration of multiple knowledge domains and expertise, from pharmaceutical sciences to engineering, from biotechnology to materials science and chemistry, from molecular imaging to clinical translation, with the ultimate objective of benefiting patients and their families.

Join Senior Director of Business Development, Daniel J. O’Connor, and Associate Vice President of Regulatory Strategies, Xavier Pepin in booth #34 to discuss your project needs.

Don’t miss our presentation at the Innovator Showcase!

Puppies Appreciate GastroPlus®: How Model-Informed Drug Development Can Reduce & Focus Clinical Trials Through Simulation
Date: Thursday, July 11th
Time: 2:30-4:30 pm CET

Model-informed drug development (MIDD) offers an accelerated path to characterize release profiles for drugs delivered through ocular, pulmonary, dermal/subq, IM, IA as well as gastrointestinal administration routes—which increases understanding, safety and efficacy while reducing costs. In this presentation, Senior Director of Business Development Dan O’Connor will highlight the newly released GastroPlus® X platform, which is revolutionizing in silico modeling and helping scientists achieve their goals!